LEADER 01382nam  2200397Ia 450 
001 9910698878503321
005 20090507161322.0
035   $a(CKB)5470000002397078
035   $a(OCoLC)320473912
035   $a(EXLCZ)995470000002397078
100   $a20090507d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eclass II special controls guidance document : in vitro HIV drug resistance genotype assay
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2007]
215   $aii, 26 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 7, 2009).
300   $a"August 2007".
300   $aIncludes bibliographical references (p. 26).
517   $aGuidance for industry 
606   $aAIDS vaccines
606   $aDrug resistance
606   $aMicrobiological assay
615  0$aAIDS vaccines.
615  0$aDrug resistance.
615  0$aMicrobiological assay.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698878503321
996   $aGuidance for industry$93434577
997   $aUNINA